Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Moderna

Australia’s COVID case count close to 10m

The total number of COVID-19 cases identified in Australia since the start of the pandemic is closing in on 10 million.

Crikey

Moderna vaccine: how the new Covid bivalent Omicron jab works

An Omicron-specific booster vaccination has been approved in the UK

Evening Standard

Is Moderna Preparing To Soar 20% And Tackle This Big Level? What To Watch On The Weekly Chart

Moderna, Inc (NASDAQ: MRNA) spiked up almost 5% off Friday’s closing price at one point on Monday, before hitting a resistance level at the $179 level and running into a group of sellers.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

First Covid-19 jab to target two strains included in autumn booster programme

Adults over 50 and clinically vulnerable people will be offered the first Covid-19 jab to target two strains of the virus, as part of the UK’s autumn booster programme.

Evening Standard

‘Next generation’ Covid booster jab to be offered to adults over 50 from autumn

Health Secretary Steve Barclay has said the vaccine will be part of the autumn booster programme.

The Independent UK

Who can get a Covid vaccine booster in the UK?

The autumn booster program for Covid vaccinations will begin shortly. Over 50s, carers, frontline health workers and those at clinical risk will be inited to get a booster jab.

Edinburgh Live

Looking At Moderna's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Covid: New dual-strain booster vaccine targeting Omicron to be rolled out in autumn

UK first country to approve use of so-called bivalent vaccine as officials prepare for winter and expected rise in Covid cases

The Independent UK

Dual-variant Covid vaccine approved for UK booster programme

Moderna jab designed to target original variant and Omicron has been given go-ahead by UK regulator

The Guardian - UK

UK takes world’s first step toward omicron-tailored shot

The U.K. has granted the world’s first approval for a COVID-19 vaccine targeting a variant in a bid to sharpen its response to an evolving coronavirus.

Tribune News Service

New covid jag approved by UK to specifically target Omicron will be fourth vaccine

Moderna’s chief medical officer, Dr Paul Burton, previously said that the new jag can boost a person’s antibodies to such high levels that it may only be needed once per year.

Daily Record

British regulator 1st to OK Moderna's updated COVID booster

British drug regulators have become the first in the world to authorize an updated version of Moderna’s coronavirus vaccine that aims to protect against the original virus and the omicron variant

The Independent UK

New Moderna vaccine to target two Covid strains in one dose

The UK has become the first country to approve the new booster, which is said will help protect people from Covid over the winter

Manchester Evening News

'Next generation' Covid jab approved in UK for use in adults

A new coronavirus booster jab has been approved for use in adults.

The National (Scotland)

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

New Omicron-specific vaccine from Moderna approved by UK regulator

New vaccine is a ‘sharpened tool in our armoury’ to fight against Covid, says Dr June Raine, chief for the UK medicines regulator

Daily Mirror

UK becomes first country to approve new Covid jab specifically targeting Omicron

Moderna's chief medical officer, Dr Paul Burton, previously said that the new jab can boost a person's antibodies to such high levels that it may only be needed annually

Evening Standard

First Covid vaccine that targets two variants approved in UK

The ‘next generation’ Moderna jab may only need to be administered once a year

The Guardian - UK

Covid vaccine designed to target two variants approved for use in UK

JCVI will decide whether to use Moderna-manufactured jab in planned autumn booster campaign

Get all your
news in one place.

100’s of premium titles.
One news app.

Wales Online

Once-a-year Covid jab approved for use in adults in UK

The new Moderna vaccine could put an end to three or four injections a year - and fights Omicron

The Independent UK

‘Next generation’ Moderna coronavirus booster jab approved for use in UK adults

The jab is the first to target two strains of Covid-19.

Asharq Al-Awsat

Southern Hemisphere to Get First mRNA Vaccine Facility

Covid-19 vaccine maker Moderna announced Monday that it will open an mRNA vaccine manufacturing facility in the Australian city of Melbourne, a first for the southern hemisphere. The project will be based at one of Australia's largest universities, Monash, and will produce 100 million vaccine doses a year for Covid-19,…

AFP

EU eyes autumn approval of Pfizer jab for Covid variants

The Hague (AFP) - The EU's medicines watchdog said Wednesday it aims to approve this autumn a Pfizer/BioNTech Covid vaccine adapted for two fast-spreading subvariants of the Omicron strain.

Benzinga

Moderna Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 14 strange trades.

Investors Business Daily

Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review

The stock market rally had mixed action, with the Nasdaq and small caps rising while the S&P 500 and oil prices fell.

Benzinga

Looking At Moderna's Recent Whale Trades

1 … 18 19 20 21

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.